Join
Login
Submit Story

 .
View All


1
digs
Anti-Drinking Ads That Engender Guilt May Not Work (HealthDay)
submitted by DrKennedy 803 days ago (via us.rd.yahoo.com)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Some types of anti-drinking ads can backfire, suggests a U.S. study.
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
A New Indicator Of Poor Prognosis In Node-Negative Colorectal Cancer Patients
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis. Several lines of evidence seem to suggest that tumor buds may, to some extent, represent malignant colorectal cancer stem cells because of their potential for migration and re-differentiation locally and at sites of metast
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Different Signaling Pathways Of Cholangiocarcinoma
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Cholangiocarcinoma (CCA), a bile duct cancer, is one of the major cancers in Northeast Thailand. This cancer is difficult to diagnose and has high metastatic and mortality rates. Overexpression of Met, a hepatocyte growth factor (HGF) receptor, has frequently been found in CCA and is correlated with progression of this type of cancer. HGF/Met activation induces a variety of cellular processes, inc
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
The Therapeutic Effect Of Worm-Derived Proteins On Experimental Colitis
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
What Do The Social Sciences Do For Me?
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Your average conversation down the pub on a Friday night could include topics such as 'the kids are driving me mad this week' or 'the litter in our street is out of control' and 'have you seen that change 4 life advert on TV?' - but the crucial research behind the topics rarely gets the same attention. Three events during the Economic and Social Research Council's (ESRC) Festival of Social Science
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Building Social Networks To Help The Disadvantaged During Disaster Recovery
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Online social networks could help with communications and recovery for people with disabilities following major natural disasters, or even terrorist attack, according to a research paper in the International Journal of Emergency Management. In the wake of Hurricanes Katrina and Rita, other natural disasters, and even technological emergencies it has become obvious that there is a serious need for
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a Genera
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
COPPERTONE(R) Solar Research Center Unveils Studies On Efficacy Of Topical Antioxidants In Sunscreens At 2010 Annual Meeting
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscreens. An ex vivo study conducted by an independent researcher for the COPPERTONE® Solar Research
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
InterMune Announces Posting Of Briefing Documents For FDA Advisory Committee Meeting On Pirfenidone
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
InterMune, Inc. (Nasdaq: ITMN) announced that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung functio
 
0 Comments - More Info - Bury   Topic: Health News
1
digs
ISIS Initiates Phase 1 Clinical Trial Of ISIS-SOD1Rx In Patients With ALS
submitted by DrKennedy 803 days ago (via feedproxy.google.com)
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS). Approximately 20 percent of all familial ALS cases are caused by a mutant form of superoxide dismutase, or SOD1. ISIS-SOD1Rx is an antisense drug designed to inhi
 
0 Comments - More Info - Bury   Topic: Health News





© 2009 www.RxSector.net - Content is available as Creative Commons Attribution-Share Alike 3.0 - Powered By PHPDug